The latest report by IMARC Group, titled “Interventional Cardiology Devices Market Report by Product (Stents, Interventional Catheters, PTCA Guidewires, Balloon Inflation Device, PTCA Balloons), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on the market.

Interventional Cardiology Devices Market Report Outlook:

The global interventional cardiology devices market size reached US$ 22.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 41.8 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032.

Factors Affecting the Growth of the Interventional Cardiology Devices Industry:

  • Rising Prevalence of Cardiovascular Diseases:

The escalating prevalence of cardiovascular diseases (CVDs), including coronary artery disease, heart failure, arrhythmias, and stroke, is propelling the market growth. This surge is attributed to a combination of genetic predispositions, lifestyle factors such as poor diet, physical inactivity, smoking, and the increasing incidence of obesity and diabetes. It has led to the demand for effective and timely interventions. In line with this, interventional cardiology devices, such as stents, catheters, and balloons, play a pivotal role in the treatment and management of CVDs by providing minimally invasive solutions that reduce the need for more invasive surgical procedures. Moreover, these devices enable the restoration of blood flow to the heart, lower chest pain, and improve the quality of life for patients with CVDs.

  • Rising geriatric Population:

The rising geriatric population, who are at a higher risk of age-related changes in the cardiovascular system, such as stiffening of the arteries and the increased prevalence of comorbid conditions like hypertension, diabetes, and obesity, is stimulating the market growth. This demographic shift requires a corresponding increase in healthcare services and interventions tailored to the needs of geriatric patients. In line with this, interventional cardiology devices offer a viable solution, providing less invasive alternatives to traditional surgical procedures, which are particularly beneficial for geriatric patients who may not tolerate open heart surgery well. Furthermore, the minimally invasive nature of these procedures, coupled with shorter recovery times and reduced hospital stays, aligns with the healthcare goals for the geriatric population.

  • Technological Advancements:

Technological advancements in interventional cardiology devices, which enhance treatment outcomes and patient experiences, are supporting the market growth. Recent innovations have led to the development of cutting-edge devices such as drug-eluting stents, which release medication to prevent the re-narrowing of arteries. Additionally, the introduction of bioresorbable stents, which naturally dissolve after restoring blood flow, is contributing to the market growth. Furthermore, the development of advanced catheterization techniques that offer precise navigation and treatment of blocked arteries is favoring the market growth. Moreover, recent improvements in imaging and diagnostic techniques, enabling more accurate assessment and targeted interventions, which in turn enhance the success rates of procedures and patient satisfaction, are positively impacting the market growth.

For an in-depth analysis, you can request a sample copy of the report: https://www.imarcgroup.com/interventional-cardiology-devices-market/requestsample

Competitive Landscape:

The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market.

  • Abbott Laboratories
  • Alvimedica
  • Braun Melsungen AG
  • Biosensors International Group Ltd. (Bluesail Medical Co. Ltd.)
  • BIOTRONIK Inc.
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • ENDOCOR GmbH
  • Koninklijke Philips N.V.
  • Medinol Ltd.
  • Medtronic plc
  • Terumo Corporation

Interventional Cardiology Devices Market Report Segmentation:

By Product:

  • Stents
    • Drug Eluting Stents
    • Bare Metal Stents
    • Bio-Absorbable Stents
  • Interventional Catheters
    • IVUS Catheters
    • Guiding Catheters
    • Angiography Catheters
  • PTCA Guidewires
  • Balloon Inflation Device
  • PTCA Balloons
    • Cutting Balloons
    • Scoring Balloons
    • Drug Eluting Balloons
    • Normal Balloons

Stents hold the majority of the market share due to their widespread use in treating coronary artery diseases by opening blocked arteries and restoring blood flow with minimal patient discomfort.

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Hospitals represented the largest market share because they are the primary settings for cardiovascular procedures, offering comprehensive care with the necessary infrastructure and expertise to perform complex interventional cardiology procedures.

Regional Insights:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America's dominance in the market is attributed to its advanced healthcare infrastructure, high prevalence of cardiovascular diseases, substantial healthcare spending, and early adoption of innovative interventional cardiology technologies.

Global Interventional Cardiology Devices Market Trends:

The rapid improvements in healthcare infrastructure, which have expanded access to healthcare services, including advanced cardiac care, are driving the market growth. Additionally, the heightened awareness among the general population about cardiovascular health, driven by public health campaigns, education initiatives, and the availability of health information online, is fueling the market growth. Besides this, the ongoing shift from volume-based care to value-based care models, encouraging the adoption of efficient and effective treatment options, including those offered by interventional cardiology, to improve patient outcomes while controlling costs, is acting as another growth-inducing factor. Furthermore, the introduction of favorable policies for cardiovascular procedures and the use of interventional cardiology devices is strengthening the market growth.

Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=5629&flag=C

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163